Medcompare - The Buyer's Guide for Medical Professionals Ophthalmology Buyer's Guide
Products New Products News Videos Journal Updates Articles Resources Events CME/CE
Search Medcompare
Enter Keyword(s):


Advertisement
Articles
The Value of the Ocular Response Analyzer (ORA) in the Assessment of Ectasia Risk in LASIK Patients
The Value of the Ocular Response Analyzer (ORA) in the Assessment of Ectasia Risk in LASIK Patients
Advertisement
> > > AlphaCor™ Artificial Cornea

AlphaCor™ Artificial Cornea

AlphaCor™ Artificial Cornea
General Information
VendorAddition Technology Inc.
ItemAlphaCor™ Artificial Cornea
FeaturesDesign:
AlphaCor is a one piece convex disc consisting of a central transparent optic and an outer skirt that is entirely manufactured from poly (2 – hydroxyethyl methacrylate) or PHEMA. AlphaCor’s material and patented features are designed to promote retention and optimize patient outcomes.

Outer Skirt:
The outer skirt is an opaque, high water content, PHEMA sponge. The porosity of the sponge encourages biointegration with host tissue and thus promotes retention of the implanted device.

Central Optic:
The central optic core is a transparent PHEMA gel providing a refractive power similar to that of the human cornea. The optic core is designed to allow the patients’ visual potential to be achieved.

The Interpenetrating Polymer Network (IPN):
The junctional zone between the skirt and central optic is the Interpenetrating Polymer Network or IPN. This is a permanent bond formed at the molecular level and is designed to prevent the down-growth of cells around the optic, which can lead to the formation of retroprosthetic membranes, one of the major complications historically associated with artificial corneas.
ApprovalUS
Product NumberInquire
PricingInquire
FinancingTo finance this purchase click here (U.S. customers only)
Related Content
Technology Spotlight  
Product Description
AlphaCor is a biocompatible, flexible, one-piece artificial cornea (keratoprosthesis) designed to replace a scarred or diseased native cornea.

The World Health Organisation (WHO) reports that corneal blindness affects more than 10 million people worldwide, however only 100,000 people receive corneal transplants each year. This shortfall is due to a combination of inadequate supply of donor corneas and the unsuitability of some patients to receive a corneal graft.

AlphaCor is designed for use in patients who have had multiple failed corneal transplants or in those patients in whom a donor graft is likely to fail.

Its patented design features are aimed to promote retention, minimize post-operative complications and restore vision in patients who cannot receive, or are unlikely to have a beneficial outcome from, a human donor graft.

AlphaCor is available in two versions, to suit those with a natural lens (phakic) or artificial lens (pseudophakic) and for those without a lens (aphakic).

View Vendor Contact Information
NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary.